Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Capital Expenditures (2016 - 2026)

Healthequity has reported Capital Expenditures over the past 14 years, most recently at -$1.6 million for Q1 2026.

  • Quarterly results put Capital Expenditures at -$1.6 million for Q1 2026, up 4.91% from a year ago — trailing twelve months through Jan 2026 was $16000.0 (down 64.44% YoY), and the annual figure for FY2026 was $16000.0, down 64.44%.
  • Capital Expenditures for Q1 2026 was -$1.6 million at Healthequity, down from $784000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for HQY hit a ceiling of $42.2 million in Q1 2023 and a floor of -$23.6 million in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $935000.0 (2022), compared with a mean of $5.1 million.
  • Biggest five-year swings in Capital Expenditures: surged 4413.58% in 2023 and later crashed 11569.8% in 2024.
  • Healthequity's Capital Expenditures stood at $2.6 million in 2022, then plummeted by 107.72% to -$202000.0 in 2023, then crashed by 11569.8% to -$23.6 million in 2024, then soared by 103.33% to $784000.0 in 2025, then plummeted by 307.53% to -$1.6 million in 2026.
  • The last three reported values for Capital Expenditures were -$1.6 million (Q1 2026), $784000.0 (Q4 2025), and -$15.2 million (Q3 2025) per Business Quant data.